US Patent Issued to HANMI PHARM. on Nov. 25 for "Imidazopyridine derivative compounds and use of same" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,845, issued on Nov. 25, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Imidazopyridine derivative compounds and use of same" was invented by In Hwan Bae (Hwaseong-si, South Korea), Won Jeoung Kim (Hwaseong-si, South Korea), Ji Sook Kim (Hwaseong-si, South Korea), Ji Young Song (Hwaseong-si, South Korea), Jae Yul Choi (Hwaseong-si, South Korea), Min Jeong Kim (Hwaseong-si, South Korea), Jung Soo Nam (Hwaseong-si, South Korea) and Young Gil Ahn (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a compound selected from a compound of chemical formula 1 having lysine-specific demethylase-1 (LSD1) inh...